STATEGICS, INC.

Biotech

Small molecule activators of the EPOR/CSF2RB tissue-protective cytokine receptor for treating neuromuscular diseases

Grants
$2.3M
5 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
4
2 granted · 2 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Development of a Homogeneous Screening Assay for the Tissue-Protective EPOR$242,013
Federal grantDepartment of Health and Human Services · Phase II · Homogeneous Screening Assay for Cytokine Receptor Modulators$722,532
Federal grantDepartment of Health and Human Services · Phase II · Homogeneous Screening Assay for Cytokine Receptor Modulators$738,401
Federal grantDepartment of Health and Human Services · Phase II · Homogeneous Screening Assay for Cytokine Receptor Modulators$515,113
Federal grantDepartment of Health and Human Services · Phase II · Homogeneous Screening Assay for Cytokine Receptor Modulators$86,761
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2559Resilience Therapeutics, Inc.—$1.4M
2560MARKER GENE TECHNOLOGIES INC——
2561Mountain Valley MD Holdings Inc.—$1.4M
2562STATEGICS, INC.——
2563Sentia Medical Sciences, Inc.——
2564Island Pharmaceuticals Ltd—$1.2M
2565LactaLogics, Inc.—$1.1M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 2 granted of 4

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.